• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

感染与胃肠道微生态的关系。

Relationship between infection and gastrointestinal microecology.

机构信息

Department of Gastroenterology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

Department of Pathology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

出版信息

Front Cell Infect Microbiol. 2022 Aug 18;12:938608. doi: 10.3389/fcimb.2022.938608. eCollection 2022.

DOI:10.3389/fcimb.2022.938608
PMID:36061875
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9433739/
Abstract

The prevalence of infection has exceeded 50% worldwide, and it is considered a high-risk factor for chronic gastritis, peptic ulcer, gastric adenocarcinoma, gastroesophageal reflux disease and functional dyspepsia. drug resistance is a common problem worldwide. In recent years, the relationship between infection and gastrointestinal microecology has received much attention. infection changes the structure and composition of gastrointestinal microflora by regulating the gastrointestinal microecological environment, local pH value, cytokines and antimicrobial peptides, and immune response and then plays a crucial role in the occurrence and development of digestive system tumors, liver metabolism and extragastrointestinal diseases. The quadruple strategy of eradication can also aggravate gastrointestinal microflora disorder. However, probiotics can reduce intestinal flora changes and imbalances through different mechanisms, thus enhancing the efficacy of eradication therapy and reducing adverse reactions caused by eradication therapy. Therefore, this paper reviews the relationship between infection and gastrointestinal microecology and its clinical application, providing a basis for clinical treatment.

摘要

全球 感染的患病率超过 50%,它被认为是慢性胃炎、消化性溃疡、胃腺癌、胃食管反流病和功能性消化不良的高危因素。耐药性是全球普遍存在的问题。近年来,感染与胃肠道微生态的关系受到了广泛关注。感染通过调节胃肠道微生态环境、局部 pH 值、细胞因子和抗菌肽以及免疫反应,改变胃肠道微生物群落的结构和组成,从而在消化系统肿瘤、肝脏代谢和胃肠道外疾病的发生和发展中发挥关键作用。根除的四联疗法也会加重胃肠道微生物群落紊乱。然而,益生菌可以通过不同的机制减少肠道菌群的变化和失衡,从而增强根除治疗的疗效,减少根除治疗引起的不良反应。因此,本文综述了感染与胃肠道微生态的关系及其临床应用,为临床治疗提供了依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1286/9433739/507834feeea9/fcimb-12-938608-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1286/9433739/a16af46510f4/fcimb-12-938608-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1286/9433739/9f064f564c9a/fcimb-12-938608-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1286/9433739/507834feeea9/fcimb-12-938608-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1286/9433739/a16af46510f4/fcimb-12-938608-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1286/9433739/9f064f564c9a/fcimb-12-938608-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1286/9433739/507834feeea9/fcimb-12-938608-g003.jpg

相似文献

1
Relationship between infection and gastrointestinal microecology.感染与胃肠道微生态的关系。
Front Cell Infect Microbiol. 2022 Aug 18;12:938608. doi: 10.3389/fcimb.2022.938608. eCollection 2022.
2
Helicobacter pylori and non-malignant upper gastrointestinal diseases.幽门螺杆菌与非恶性上消化道疾病
Helicobacter. 2016 Sep;21 Suppl 1:30-3. doi: 10.1111/hel.12337.
3
Impact of non-steroidal anti-inflammatory drug and aspirin use on the prevalence of dyspepsia and uncomplicated peptic ulcer disease.非甾体抗炎药和阿司匹林的使用对消化不良和单纯性消化性溃疡疾病患病率的影响。
Scand J Gastroenterol. 2001 Aug;36(8):817-21. doi: 10.1080/003655201750313333.
4
Strategy for treatment of Helicobacter pylori infection in adults. I. Updated indications for test and eradication therapy suggested in 2000.成人幽门螺杆菌感染的治疗策略。I. 2000年建议的检测与根除治疗的更新指征。
Curr Pharm Des. 2000 Oct;6(15):1503-14. doi: 10.2174/1381612003399112.
5
First-line treatment of Helicobacter pylori in Lebanon: Comparison of bismuth-containing quadruple therapy versus 14-days sequential therapy.黎巴嫩幽门螺杆菌的一线治疗:含铋四联疗法与 14 天序贯疗法的比较。
Microb Pathog. 2018 Apr;117:23-26. doi: 10.1016/j.micpath.2018.02.010. Epub 2018 Feb 8.
6
Helicobacter pylori infection and nonmalignant diseases.幽门螺杆菌感染与非恶性疾病。
Helicobacter. 2017 Sep;22 Suppl 1. doi: 10.1111/hel.12408.
7
[Eradication of Helicobacter pylori. Is it necessary to eradicate Helicobacter pylori in gastric reflux?].[幽门螺杆菌的根除。胃反流中是否有必要根除幽门螺杆菌?]
Presse Med. 2001 Sep 22;30(26):1313-20.
8
CagA status and Helicobacter pylori eradication among dyspeptic patients.消化不良患者的细胞毒素相关基因A(CagA)状态与幽门螺杆菌根除情况
Gastroenterol Hepatol. 2005 Oct;28(8):441-4. doi: 10.1157/13078993.
9
Changes in plasma ghrelin and leptin levels in patients with peptic ulcer and gastritis following eradication of Helicobacter pylori infection.幽门螺杆菌感染根除后消化性溃疡和胃炎患者血浆胃饥饿素和瘦素水平的变化
BMC Gastroenterol. 2016 Oct 4;16(1):119. doi: 10.1186/s12876-016-0532-2.
10
Helicobacter pylori and nonmalignant upper gastrointestinal diseases.幽门螺杆菌与非恶性上消化道疾病。
Helicobacter. 2018 Sep;23 Suppl 1:e12522. doi: 10.1111/hel.12522.

引用本文的文献

1
and Compositional Patterns of Digestive Tract Microbiome in Children: A Literature Review.儿童消化道微生物群的组成模式:文献综述
Nutrients. 2025 Aug 21;17(16):2711. doi: 10.3390/nu17162711.
2
Postbiotics enhance the efficacy of derivative compound mouthwash against clinical strains.后生元可增强衍生复合漱口水对临床菌株的疗效。
Front Cell Infect Microbiol. 2025 Jul 23;15:1629106. doi: 10.3389/fcimb.2025.1629106. eCollection 2025.
3
A novel method for precise endoscopic sampling of duodenal microbiota.一种精确采集十二指肠微生物群的新型内镜采样方法。

本文引用的文献

1
Altered Gut Microbiota and Short-Chain Fatty Acids After Vonoprazan-Amoxicillin Dual Therapy for Eradication.**标题**:**沃诺拉赞-阿莫西林双联疗法根除后肠道微生物群和短链脂肪酸的变化** **原文**:Altered Gut Microbiota and Short-Chain Fatty Acids After Vonoprazan-Amoxicillin Dual Therapy for Eradication. **译文**:沃诺拉赞-阿莫西林双联疗法根除后肠道微生物群和短链脂肪酸的变化。
Front Cell Infect Microbiol. 2022 Jun 2;12:881968. doi: 10.3389/fcimb.2022.881968. eCollection 2022.
2
Antibacterial Effects of Bacteriocin PLNC8 against and Its Potential Mechanism of Action.细菌素PLNC8的抗菌作用及其潜在作用机制
Foods. 2022 Apr 25;11(9):1235. doi: 10.3390/foods11091235.
3
Front Cell Infect Microbiol. 2025 Jul 18;15:1517751. doi: 10.3389/fcimb.2025.1517751. eCollection 2025.
4
Microbiota-driven epigenetic modifications in gastrointestinal cancer: Implications for pathogenesis and therapeutic strategies.微生物群驱动的胃肠道癌表观遗传修饰:对发病机制和治疗策略的影响
World J Microbiol Biotechnol. 2025 Jul 28;41(8):288. doi: 10.1007/s11274-025-04457-w.
5
Beyond antibiotics: probiotics as a promising ally against .超越抗生素:益生菌成为对抗……的有前景盟友
Front Pharmacol. 2025 Jul 11;16:1620870. doi: 10.3389/fphar.2025.1620870. eCollection 2025.
6
Towards Effective Eradication: Emerging Therapies in the Wake of Antibiotic Resistance.迈向有效根除:抗生素耐药性背景下的新兴疗法
Int J Mol Sci. 2025 Jun 24;26(13):6064. doi: 10.3390/ijms26136064.
7
Tripartite interplay: immune reconstitution dynamics in AIDS, gut microbiota, and Helicobacter pylori infection: current advances and therapeutic prospects.三方相互作用:艾滋病、肠道微生物群和幽门螺杆菌感染中的免疫重建动态:当前进展与治疗前景
Gut Pathog. 2025 Jul 3;17(1):50. doi: 10.1186/s13099-025-00726-z.
8
Research progress on fecal microbiota transplantation in tumor prevention and treatment.粪便微生物群移植在肿瘤防治中的研究进展
Open Life Sci. 2025 Apr 1;20(1):20220954. doi: 10.1515/biol-2022-0954. eCollection 2025.
9
Innate Immunity in Helicobacter pylori Infection and Gastric Oncogenesis.幽门螺杆菌感染与胃癌发生中的天然免疫
Helicobacter. 2025 Mar-Apr;30(2):e70015. doi: 10.1111/hel.70015.
10
infection process: from the molecular world to clinical treatment.感染过程:从分子世界到临床治疗
Front Microbiol. 2025 Feb 27;16:1541140. doi: 10.3389/fmicb.2025.1541140. eCollection 2025.
Effect of Probiotic-Assisted Eradication of +/ on Intestinal Flora.
益生菌辅助清除+/对肠道菌群的影响。
Biomed Res Int. 2022 Apr 29;2022:8607671. doi: 10.1155/2022/8607671. eCollection 2022.
4
Reshapes the Gut Microbiota to Alleviate the Subhealth.重塑肠道微生物群以缓解亚健康。
Nutrients. 2022 Apr 14;14(8):1642. doi: 10.3390/nu14081642.
5
Role of Gastric Microorganisms Other than in the Development and Treatment of Gastric Diseases.除幽门螺杆菌外的胃微生物在胃部疾病发生与治疗中的作用 。 (注:原文中“Other than ”后面缺少具体内容,这里按常规理解补充了“幽门螺杆菌”,如果实际不是这个意思,请根据正确内容进行调整)
Biomed Res Int. 2022 Mar 14;2022:6263423. doi: 10.1155/2022/6263423. eCollection 2022.
6
The immune microenvironment in gastric adenocarcinoma.胃腺癌的免疫微环境。
Nat Rev Gastroenterol Hepatol. 2022 Jul;19(7):451-467. doi: 10.1038/s41575-022-00591-0. Epub 2022 Mar 14.
7
Bacillus subtilis inhibits intestinal inflammation and oxidative stress by regulating gut flora and related metabolites in laying hens.枯草芽孢杆菌通过调节蛋鸡肠道菌群及相关代谢产物来抑制肠道炎症和氧化应激。
Animal. 2022 Mar;16(3):100474. doi: 10.1016/j.animal.2022.100474. Epub 2022 Feb 24.
8
infection: How does age influence the inflammatory pattern?感染:年龄如何影响炎症模式?
World J Gastroenterol. 2022 Jan 28;28(4):402-411. doi: 10.3748/wjg.v28.i4.402.
9
Progress in elucidating the relationship between infection and intestinal diseases.阐明感染与肠道疾病之间关系的研究进展。
World J Gastroenterol. 2021 Dec 21;27(47):8040-8046. doi: 10.3748/wjg.v27.i47.8040.
10
Gastrointestinal Microbiota Changes in Patients With Gastric Precancerous Lesions.胃前病变患者的胃肠道微生物群变化。
Front Cell Infect Microbiol. 2021 Dec 9;11:749207. doi: 10.3389/fcimb.2021.749207. eCollection 2021.